<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00807885</url>
  </required_header>
  <id_info>
    <org_study_id>1838-007</org_study_id>
    <nct_id>NCT00807885</nct_id>
  </id_info>
  <brief_title>Study of Techniques of Subcutaneous Administration of Fluids Enabled by Human Recombinant Hyaluronidase</brief_title>
  <acronym>INFUSE-AT</acronym>
  <official_title>INcreased Flow Utilizing Subcutaneously-Enabled Fluids Administration Technique Study (INFUSE-AT): A Randomized, Open-Label, Parallel Group, Phase IV, Study Evaluating the Techniques of Administration of Subcutaneous Fluids Enabled by Human Recombinant Hyaluronidase (Hylenex) in Healthy Adult Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baxter Healthcare Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Halozyme Therapeutics</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Baxter Healthcare Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose is to evaluate the ease of use and technical challenges encountered during
      subcutaneous infusion of Lactated Ringer's (LR) solution, preceded by recombinant human
      hyaluronidase (hylenex), utilizing commonly used angiocatheter gauges and button delivery
      systems. The safety and tolerability of hylenex-augmented SC infusion of LR through these
      delivery systems is also being evaluated.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2008</start_date>
  <completion_date type="Actual">January 2009</completion_date>
  <primary_completion_date type="Actual">January 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Technical Challenges</measure>
    <time_frame>throughout subcutaneous hylenex and fluid administration period (continuous)</time_frame>
    <description>Protocol-specified challenges encountered during subcutaneous (SC) hylenex administration and/or SC infusion of Lactated Ringer's solution, including SC catheter kinking, catheter/button dislodgement, catheter/button pull-out, infusion pump alarm, other pump failure, healthcare provider intervention to secure/maintain SC infusion eg, re-taping, catheter/button manipulation, etc, and any other type of technical challenge encountered</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Attempts Needed to Successfully Place Subcutaneous Catheter/Button</measure>
    <time_frame>from start of first attempt until completion of catheter/button placement</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time Needed to Successfully Place Subcutaneous Catheter/Button</measure>
    <time_frame>from start of first attempt until completion of catheter/button placement</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time Required to Infuse 1000 mL Fluid</measure>
    <time_frame>from start of Lactated Ringer's (LR) infusion until 1000 mL LR infused</time_frame>
  </secondary_outcome>
  <number_of_arms>9</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Dehydration</condition>
  <arm_group>
    <arm_group_label>Tegaderm-secured 24 ga Teflon catheter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subcutaneous administration of a single 150 U dose of hylenex, followed by subcutaneous infusion (delivered by large volume infusion pump) of 1000 mL Lactated Ringer's solution, both delivered through a 24-gauge, 0.75 inch long, Teflon angiocatheter secured with Tegaderm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tape-secured 24 ga Teflon catheter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subcutaneous administration of a single 150 U dose of hylenex, followed by subcutaneous infusion (delivered by large volume infusion pump) of 1000 mL Lactated Ringer's solution, both delivered through a 24-gauge, 0.75 inch long, Teflon angiocatheter secured with a tape double chevron</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tegaderm-secured 24 ga polyurethane catheter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subcutaneous administration of a single 150 U dose of hylenex, followed by subcutaneous infusion (delivered by large volume infusion pump) of 1000 mL Lactated Ringer's solution, both delivered through a 24-gauge, 0.75 inch long, polyurethane angiocatheter secured with Tegaderm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tape-secured 24 ga polyurethane catheter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subcutaneous administration of a single 150 U dose of hylenex, followed by subcutaneous infusion (delivered by large volume infusion pump) of 1000 mL Lactated Ringer's solution, both delivered through a 24-gauge, 0.75 inch long, polyurethane angiocatheter secured with a tape double chevron</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tegaderm-secured 20 ga Teflon catheter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subcutaneous administration of a single 150 U dose of hylenex, followed by subcutaneous infusion (delivered by large volume infusion pump) of 1000 mL Lactated Ringer's solution, both delivered through a 20-gauge, 1.0 inch long, Teflon angiocatheter secured with Tegaderm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tape-secured 20 ga Teflon catheter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subcutaneous administration of a single 150 U dose of hylenex, followed by subcutaneous infusion (delivered by large volume infusion pump) of 1000 mL Lactated Ringer's solution, both delivered through a 20-gauge, 1.0 inch long, Teflon angiocatheter secured with a tape double chevron</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tegaderm-secured 20 ga polyurethane catheter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subcutaneous administration of a single 150 U dose of hylenex, followed by subcutaneous infusion (delivered by large volume infusion pump) of 1000 mL Lactated Ringer's solution, both delivered through a 20-gauge, 1.0 inch long, polyurethane angiocatheter secured with Tegaderm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tape-secured 20 ga polyurethane catheter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subcutaneous administration of a single 150 U dose of hylenex, followed by subcutaneous infusion (delivered by large volume infusion pump) of 1000 mL Lactated Ringer's solution, both delivered through a 20-gauge, 1.0 inch long, polyurethane angiocatheter secured with a tape double chevron</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SC button with 27 ga X 9 mm needle</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subcutaneous administration of a single 150 U dose of hylenex, followed by subcutaneous infusion (delivered by large volume infusion pump) of 1000 mL Lactated Ringer's solution, both delivered through a button-type subcutaneous delivery system (with a 27-gauge, 9 mm long metal needle)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>hylenex-facilitated subcutaneous Lactated Ringer's infusion</intervention_name>
    <description>single subcutaneous 150 U dose of hylenex, followed by subcutaneous infusion of 1000 mL Lactated Ringer's solution</description>
    <arm_group_label>Tegaderm-secured 24 ga Teflon catheter</arm_group_label>
    <arm_group_label>Tape-secured 24 ga Teflon catheter</arm_group_label>
    <arm_group_label>Tegaderm-secured 24 ga polyurethane catheter</arm_group_label>
    <arm_group_label>Tape-secured 24 ga polyurethane catheter</arm_group_label>
    <arm_group_label>Tegaderm-secured 20 ga Teflon catheter</arm_group_label>
    <arm_group_label>Tape-secured 20 ga Teflon catheter</arm_group_label>
    <arm_group_label>Tegaderm-secured 20 ga polyurethane catheter</arm_group_label>
    <arm_group_label>Tape-secured 20 ga polyurethane catheter</arm_group_label>
    <arm_group_label>SC button with 27 ga X 9 mm needle</arm_group_label>
    <other_name>hylenex</other_name>
    <other_name>rHuPH20</other_name>
    <other_name>LR</other_name>
    <other_name>LR solution</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male or female, aged 18 to 60 years

          -  intact normal skin without potentially obscuring features on both anterior thighs in
             the area intended for infusion

          -  agreeing to no fluid intake for 12 hours prior to start of study infusion

          -  vital signs within normal range or, if outside normal range, deemed not clinically
             significant

          -  metabolic panel, hematology, virology and standard 10-test urine dipstick tests within
             normal range, or if outside normal range, deemed not clinically significant

          -  if female of child-bearing potential,negative serum pregnancy tests

          -  negative urine drug screens

          -  written informed consent for participation

        Exclusion Criteria:

          -  lower extremity edema

          -  lower extremity pathology that could interfere with study outcome

          -  history of cardiovascular disease

          -  rales on lung auscultation

          -  known allergy to hyaluronidase or other ingredient in the formulation of hylenex

          -  pregnancy or breast-feeding a child

          -  exposure to any experimental drug within 30 days prior to study participation

          -  previous participation in this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>George Harb, MD, MPH</last_name>
    <role>Study Director</role>
    <affiliation>Baxter Healthcare Corporation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>MDS Pharma Services</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68502</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MDS Pharma Services</name>
      <address>
        <city>Neptune</city>
        <state>New Jersey</state>
        <zip>07753</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 10, 2008</study_first_submitted>
  <study_first_submitted_qc>December 11, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 12, 2008</study_first_posted>
  <results_first_submitted>September 12, 2011</results_first_submitted>
  <results_first_submitted_qc>September 12, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 18, 2011</results_first_posted>
  <last_update_submitted>October 21, 2011</last_update_submitted>
  <last_update_submitted_qc>October 21, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 26, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>dehydration</keyword>
  <keyword>fluid therapy</keyword>
  <keyword>hyaluronoglucosaminidase</keyword>
  <keyword>hyaluronidase</keyword>
  <keyword>hypodermoclysis</keyword>
  <keyword>clysis</keyword>
  <keyword>subcutaneous hydration</keyword>
  <keyword>subcutaneous rehydration</keyword>
  <keyword>hyaluronan</keyword>
  <keyword>rHuPH20</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dehydration</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Tegaderm-secured 24 ga Teflon Catheter</title>
        </group>
        <group group_id="P2">
          <title>Tape-secured 24 ga Teflon Catheter</title>
        </group>
        <group group_id="P3">
          <title>Tegaderm-secured 24 ga Polyurethane Catheter</title>
        </group>
        <group group_id="P4">
          <title>Tape-secured 24 ga Polyurethane Catheter</title>
        </group>
        <group group_id="P5">
          <title>Tegaderm-secured 20 ga Teflon Catheter</title>
        </group>
        <group group_id="P6">
          <title>Tape-secured 20 ga Teflon Catheter</title>
        </group>
        <group group_id="P7">
          <title>Tegaderm-secured 20 ga Polyurethane Catheter</title>
        </group>
        <group group_id="P8">
          <title>Tape-secured 20 ga Polyurethane Catheter</title>
        </group>
        <group group_id="P9">
          <title>SC Button With 27 ga X 9 mm Needle</title>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="11"/>
                <participants group_id="P3" count="11"/>
                <participants group_id="P4" count="10"/>
                <participants group_id="P5" count="12"/>
                <participants group_id="P6" count="12"/>
                <participants group_id="P7" count="12"/>
                <participants group_id="P8" count="11"/>
                <participants group_id="P9" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="11"/>
                <participants group_id="P3" count="11"/>
                <participants group_id="P4" count="10"/>
                <participants group_id="P5" count="12"/>
                <participants group_id="P6" count="11">Subject completed treatment, but lost to follow-up</participants>
                <participants group_id="P7" count="12"/>
                <participants group_id="P8" count="11"/>
                <participants group_id="P9" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Tegaderm-secured 24 ga Teflon Catheter</title>
        </group>
        <group group_id="B2">
          <title>Tape-secured 24 ga Teflon Catheter</title>
        </group>
        <group group_id="B3">
          <title>Tegaderm-secured 24 ga Polyurethane Catheter</title>
        </group>
        <group group_id="B4">
          <title>Tape-secured 24 ga Polyurethane Catheter</title>
        </group>
        <group group_id="B5">
          <title>Tegaderm-secured 20 ga Teflon Catheter</title>
        </group>
        <group group_id="B6">
          <title>Tape-secured 20 ga Teflon Catheter</title>
        </group>
        <group group_id="B7">
          <title>Tegaderm-secured 20 ga Polyurethane Catheter</title>
        </group>
        <group group_id="B8">
          <title>Tape-secured 20 ga Polyurethane Catheter</title>
        </group>
        <group group_id="B9">
          <title>SC Button With 27 ga X 9 mm Needle</title>
        </group>
        <group group_id="B10">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="11"/>
            <count group_id="B3" value="11"/>
            <count group_id="B4" value="10"/>
            <count group_id="B5" value="12"/>
            <count group_id="B6" value="12"/>
            <count group_id="B7" value="12"/>
            <count group_id="B8" value="11"/>
            <count group_id="B9" value="11"/>
            <count group_id="B10" value="100"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="10"/>
                    <measurement group_id="B5" value="12"/>
                    <measurement group_id="B6" value="12"/>
                    <measurement group_id="B7" value="12"/>
                    <measurement group_id="B8" value="11"/>
                    <measurement group_id="B9" value="11"/>
                    <measurement group_id="B10" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34.6" spread="9.39"/>
                    <measurement group_id="B2" value="36.0" spread="10.6"/>
                    <measurement group_id="B3" value="33.8" spread="10.4"/>
                    <measurement group_id="B4" value="35.3" spread="10.9"/>
                    <measurement group_id="B5" value="34.0" spread="12.5"/>
                    <measurement group_id="B6" value="34.3" spread="10.3"/>
                    <measurement group_id="B7" value="33.6" spread="10.7"/>
                    <measurement group_id="B8" value="32.4" spread="12.7"/>
                    <measurement group_id="B9" value="36.6" spread="12.3"/>
                    <measurement group_id="B10" value="34.5" spread="10.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="3"/>
                    <measurement group_id="B6" value="6"/>
                    <measurement group_id="B7" value="5"/>
                    <measurement group_id="B8" value="4"/>
                    <measurement group_id="B9" value="5"/>
                    <measurement group_id="B10" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="7"/>
                    <measurement group_id="B5" value="9"/>
                    <measurement group_id="B6" value="6"/>
                    <measurement group_id="B7" value="7"/>
                    <measurement group_id="B8" value="7"/>
                    <measurement group_id="B9" value="6"/>
                    <measurement group_id="B10" value="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="10"/>
                    <measurement group_id="B5" value="12"/>
                    <measurement group_id="B6" value="12"/>
                    <measurement group_id="B7" value="12"/>
                    <measurement group_id="B8" value="11"/>
                    <measurement group_id="B9" value="11"/>
                    <measurement group_id="B10" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Technical Challenges</title>
        <description>Protocol-specified challenges encountered during subcutaneous (SC) hylenex administration and/or SC infusion of Lactated Ringer's solution, including SC catheter kinking, catheter/button dislodgement, catheter/button pull-out, infusion pump alarm, other pump failure, healthcare provider intervention to secure/maintain SC infusion eg, re-taping, catheter/button manipulation, etc, and any other type of technical challenge encountered</description>
        <time_frame>throughout subcutaneous hylenex and fluid administration period (continuous)</time_frame>
        <population>ITT (all treated subjects)</population>
        <group_list>
          <group group_id="O1">
            <title>Tegaderm-secured 24 ga Teflon Catheter</title>
          </group>
          <group group_id="O2">
            <title>Tape-secured 24 ga Teflon Catheter</title>
          </group>
          <group group_id="O3">
            <title>Tegaderm-secured 24 ga Polyurethane Catheter</title>
          </group>
          <group group_id="O4">
            <title>Tape-secured 24 ga Polyurethane Catheter</title>
          </group>
          <group group_id="O5">
            <title>Tegaderm-secured 20 ga Teflon Catheter</title>
          </group>
          <group group_id="O6">
            <title>Tape-secured 20 ga Teflon Catheter</title>
          </group>
          <group group_id="O7">
            <title>Tegaderm-secured 20 ga Polyurethane Catheter</title>
          </group>
          <group group_id="O8">
            <title>Tape-secured 20 ga Polyurethane Catheter</title>
          </group>
          <group group_id="O9">
            <title>SC Button With 27 ga X 9 mm Needle</title>
          </group>
        </group_list>
        <measure>
          <title>Technical Challenges</title>
          <description>Protocol-specified challenges encountered during subcutaneous (SC) hylenex administration and/or SC infusion of Lactated Ringer's solution, including SC catheter kinking, catheter/button dislodgement, catheter/button pull-out, infusion pump alarm, other pump failure, healthcare provider intervention to secure/maintain SC infusion eg, re-taping, catheter/button manipulation, etc, and any other type of technical challenge encountered</description>
          <population>ITT (all treated subjects)</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="11"/>
                <count group_id="O4" value="10"/>
                <count group_id="O5" value="12"/>
                <count group_id="O6" value="12"/>
                <count group_id="O7" value="12"/>
                <count group_id="O8" value="11"/>
                <count group_id="O9" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Subjects with at Least One Technical Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Subjects with No Technical Challenges</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="9"/>
                    <measurement group_id="O4" value="8"/>
                    <measurement group_id="O5" value="10"/>
                    <measurement group_id="O6" value="10"/>
                    <measurement group_id="O7" value="9"/>
                    <measurement group_id="O8" value="9"/>
                    <measurement group_id="O9" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Subjects with 1 TEchnical Challenge</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Subjects with 2 Technical Challenges</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Subjects with 3 Technical Challenges</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Subjects with Catheter Kinking</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="2"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Subjects with Catheter Dislodgement</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Subjects with Catheter Pulled Out</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Subjects with Infusion Pump Alarm</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Subjects with Infusion Pump Failure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Attempts Needed to Successfully Place Subcutaneous Catheter/Button</title>
        <time_frame>from start of first attempt until completion of catheter/button placement</time_frame>
        <population>ITT (all treated subjects)</population>
        <group_list>
          <group group_id="O1">
            <title>Tegaderm-secured 24 ga Teflon Catheter</title>
          </group>
          <group group_id="O2">
            <title>Tape-secured 24 ga Teflon Catheter</title>
          </group>
          <group group_id="O3">
            <title>Tegaderm-secured 24 ga Polyurethane Catheter</title>
          </group>
          <group group_id="O4">
            <title>Tape-secured 24 ga Polyurethane Catheter</title>
          </group>
          <group group_id="O5">
            <title>Tegaderm-secured 20 ga Teflon Catheter</title>
          </group>
          <group group_id="O6">
            <title>Tape-secured 20 ga Teflon Catheter</title>
          </group>
          <group group_id="O7">
            <title>Tegaderm-secured 20 ga Polyurethane Catheter</title>
          </group>
          <group group_id="O8">
            <title>Tape-secured 20 ga Polyurethane Catheter</title>
          </group>
          <group group_id="O9">
            <title>SC Button With 27 ga X 9 mm Needle</title>
          </group>
        </group_list>
        <measure>
          <title>Attempts Needed to Successfully Place Subcutaneous Catheter/Button</title>
          <population>ITT (all treated subjects)</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="11"/>
                <count group_id="O4" value="10"/>
                <count group_id="O5" value="12"/>
                <count group_id="O6" value="12"/>
                <count group_id="O7" value="12"/>
                <count group_id="O8" value="11"/>
                <count group_id="O9" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1 Attempt</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="10"/>
                    <measurement group_id="O5" value="12"/>
                    <measurement group_id="O6" value="11"/>
                    <measurement group_id="O7" value="12"/>
                    <measurement group_id="O8" value="11"/>
                    <measurement group_id="O9" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 Attempts</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time Needed to Successfully Place Subcutaneous Catheter/Button</title>
        <time_frame>from start of first attempt until completion of catheter/button placement</time_frame>
        <population>ITT (all treated subjects)</population>
        <group_list>
          <group group_id="O1">
            <title>Tegaderm-secured 24 ga Teflon Catheter</title>
          </group>
          <group group_id="O2">
            <title>Tape-secured 24 ga Teflon Catheter</title>
          </group>
          <group group_id="O3">
            <title>Tegaderm-secured 24 ga Polyurethane Catheter</title>
          </group>
          <group group_id="O4">
            <title>Tape-secured 24 ga Polyurethane Catheter</title>
          </group>
          <group group_id="O5">
            <title>Tegaderm-secured 20 ga Teflon Catheter</title>
          </group>
          <group group_id="O6">
            <title>Tape-secured 20 ga Teflon Catheter</title>
          </group>
          <group group_id="O7">
            <title>Tegaderm-secured 20 ga Polyurethane Catheter</title>
          </group>
          <group group_id="O8">
            <title>Tape-secured 20 ga Polyurethane Catheter</title>
          </group>
          <group group_id="O9">
            <title>SC Button With 27 ga X 9 mm Needle</title>
          </group>
        </group_list>
        <measure>
          <title>Time Needed to Successfully Place Subcutaneous Catheter/Button</title>
          <population>ITT (all treated subjects)</population>
          <units>seconds</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="11"/>
                <count group_id="O4" value="10"/>
                <count group_id="O5" value="12"/>
                <count group_id="O6" value="12"/>
                <count group_id="O7" value="12"/>
                <count group_id="O8" value="11"/>
                <count group_id="O9" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23" lower_limit="1" upper_limit="39"/>
                    <measurement group_id="O2" value="43" lower_limit="2" upper_limit="84"/>
                    <measurement group_id="O3" value="30" lower_limit="2" upper_limit="63"/>
                    <measurement group_id="O4" value="34" lower_limit="10" upper_limit="96"/>
                    <measurement group_id="O5" value="30" lower_limit="2" upper_limit="58"/>
                    <measurement group_id="O6" value="49" lower_limit="2" upper_limit="133"/>
                    <measurement group_id="O7" value="31" lower_limit="1" upper_limit="90"/>
                    <measurement group_id="O8" value="15" lower_limit="1" upper_limit="96"/>
                    <measurement group_id="O9" value="9" lower_limit="1" upper_limit="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time Required to Infuse 1000 mL Fluid</title>
        <time_frame>from start of Lactated Ringer's (LR) infusion until 1000 mL LR infused</time_frame>
        <population>ITT (all treated subjects)</population>
        <group_list>
          <group group_id="O1">
            <title>Tegaderm-secured 24 ga Teflon Catheter</title>
          </group>
          <group group_id="O2">
            <title>Tape-secured 24 ga Teflon Catheter</title>
          </group>
          <group group_id="O3">
            <title>Tegaderm-secured 24 ga Polyurethane Catheter</title>
          </group>
          <group group_id="O4">
            <title>Tape-secured 24 ga Polyurethane Catheter</title>
          </group>
          <group group_id="O5">
            <title>Tegaderm-secured 20 ga Teflon Catheter</title>
          </group>
          <group group_id="O6">
            <title>Tape-secured 20 ga Teflon Catheter</title>
          </group>
          <group group_id="O7">
            <title>Tegaderm-secured 20 ga Polyurethane Catheter</title>
          </group>
          <group group_id="O8">
            <title>Tape-secured 20 ga Polyurethane Catheter</title>
          </group>
          <group group_id="O9">
            <title>SC Button With 27 ga X 9 mm Needle</title>
          </group>
        </group_list>
        <measure>
          <title>Time Required to Infuse 1000 mL Fluid</title>
          <population>ITT (all treated subjects)</population>
          <units>hours</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="11"/>
                <count group_id="O4" value="10"/>
                <count group_id="O5" value="12"/>
                <count group_id="O6" value="12"/>
                <count group_id="O7" value="12"/>
                <count group_id="O8" value="11"/>
                <count group_id="O9" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.82" spread="0.058"/>
                    <measurement group_id="O2" value="6.78" spread="0.098"/>
                    <measurement group_id="O3" value="6.81" spread="0.013"/>
                    <measurement group_id="O4" value="6.80" spread="0.114"/>
                    <measurement group_id="O5" value="6.78" spread="0.071"/>
                    <measurement group_id="O6" value="6.80" spread="0.013"/>
                    <measurement group_id="O7" value="6.81" spread="0.078"/>
                    <measurement group_id="O8" value="6.79" spread="0.108"/>
                    <measurement group_id="O9" value="6.82" spread="0.078"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 d post-treatment</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Tegaderm-secured 24 ga Teflon Catheter</title>
        </group>
        <group group_id="E2">
          <title>Tape-secured 24 ga Teflon Catheter</title>
        </group>
        <group group_id="E3">
          <title>Tegaderm-secured 24 ga Polyurethane Catheter</title>
        </group>
        <group group_id="E4">
          <title>Tape-secured 24 ga Polyurethane Catheter</title>
        </group>
        <group group_id="E5">
          <title>Tegaderm-secured 20 ga Teflon Catheter</title>
        </group>
        <group group_id="E6">
          <title>Tape-secured 20 ga Teflon Catheter</title>
        </group>
        <group group_id="E7">
          <title>Tegaderm-secured 20 ga Polyurethane Catheter</title>
        </group>
        <group group_id="E8">
          <title>Tape-secured 20 ga Polyurethane Catheter</title>
        </group>
        <group group_id="E9">
          <title>SC Button With 27 ga X 9 mm Needle</title>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (11.0)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>calculus ureteric</sub_title>
                <description>Unrelated to treatment</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA (11.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="11"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="10"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="10" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="10" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="10" subjects_at_risk="11"/>
                <counts group_id="E9" subjects_affected="8" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Infusion site erythema</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="11"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="11"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="11"/>
              </event>
              <event>
                <sub_title>Infusion site pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="11"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="9" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="8" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="8" subjects_at_risk="11"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="11"/>
              </event>
              <event>
                <sub_title>Infusion site swelling</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>For this study, Baxter requires a review of any planned PI results communications (eg, for confidential information) up to 90 days prior to submission or communication. Baxter may request an additional delay of up to 60 days (eg, to allow for intellectual property protection).</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>George Harb, MD, MPH</name_or_title>
      <organization>Baxter Healthcare Corporation</organization>
      <email>george_harb@baxter.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

